Viral CTL Escape Mutants Are Generated in Lymph Nodes and Subsequently Become Fixed in Plasma and Rectal Mucosa during Acute SIV Infection of Macaques

English version České info

SIV_mac239 infection of rhesus macaques (RMs) results in AIDS despite the generation of a strong antiviral cytotoxic T lymphocyte (CTL) response, possibly due to the emergence of viral escape mutants that prevent recognition of infected cells by CTLs. To determine the anatomic origin of these SIV mutants, we longitudinally assessed the presence of CTL escape variants in two MamuA*01-restricted immunodominant epitopes (Tat-SL8 and Gag-CM9) in the plasma, PBMCs, lymph nodes (LN), and rectal biopsies (RB) of fifteen SIV_mac239-infected RMs. As expected, Gag-CM9 did not exhibit signs of escape before day 84 post infection. In contrast, Tat-SL8 escape mutants were apparent in all tissues by day 14 post infection. Interestingly LNs and plasma exhibited the highest level of escape at day 14 and day 28 post infection, respectively, with the rate of escape in the RB remaining lower throughout the acute infection. The possibility that CTL escape occurs in LNs before RBs is confirmed by the observation that the specific mutants found at high frequency in LNs at day 14 post infection became dominant at day 28 post infection in plasma, PBMC, and RB. Finally, the frequency of escape mutants in plasma at day 28 post infection correlated strongly with the level Tat-SL8-specific CD8 T cells in the LN and PBMC at day 14 post infection. These results indicate that LNs represent the primary source of CTL escape mutants during the acute phase of SIV_mac239 infection, suggesting that LNs are the main anatomic sites of virus replication and/or the tissues in which CTL pressure is most effective in selecting SIV escape variants.

Vyšlo v časopise: Viral CTL Escape Mutants Are Generated in Lymph Nodes and Subsequently Become Fixed in Plasma and Rectal Mucosa during Acute SIV Infection of Macaques. PLoS Pathog 7(5): e32767. doi:10.1371/journal.ppat.1002048
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002048

Souhrn

Zdroje

1. KorberBGnanakaranS 2009 The implications of patterns in HIV diversity for neutralizing antibody induction and susceptibility. Curr Opin HIV AIDS 4 408 417

2. KouyosRDAlthausCLBonhoefferS 2006 Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14 507 511

3. Karlsson HedestamGBFouchierRAPhogatSBurtonDRSodroskiJ 2008 The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6 143 155

4. PantophletRBurtonDR 2006 GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24 739 769

5. LetvinNL 2007 Correlates of immune protection and the development of a human immunodeficiency virus vaccine. Immunity 27 366 369

6. KannagiMChalifouxLVLordCILetvinNL 1988 Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J Immunol 140 2237 2242

7. WalkerCMMoodyDJStitesDPLevyJA 1986 CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234 1563 1566

8. BorrowPLewickiHHahnBHShawGMOldstoneMB 1994 Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68 6103 6110

9. KoupRASafritJTCaoYAndrewsCAMcLeodG 1994 Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68 4650 4655

10. JinXBauerDETuttletonSELewinSGettieA 1999 Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189 991 998

11. MatanoTShibataRSiemonCConnorsMLaneHC 1998 Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 72 164 169

12. SchmitzJEKurodaMJSantraSSassevilleVGSimonMA 1999 Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 857 860

13. GoulderPJWatkinsDI 2004 HIV and SIV CTL escape: implications for vaccine design. Nat Rev Immunol 4 630 640

14. AllenTMO'ConnorDHJingPDzurisJLMotheBR 2000 Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407 386 390

15. AllenTMSidneyJdel GuercioMFGlickmanRLLensmeyerGL 1998 Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. J Immunol 160 6062 6071

16. MotheBRHortonHCarterDKAllenTMLieblME 2002 Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol 76 875 884

17. BarouchDHKunstmanJGlowczwskieJKunstmanKJEganMA 2003 Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J Virol 77 7367 7375

18. BarouchDHKunstmanJKurodaMJSchmitzJESantraS 2002 Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415 335 339

19. FriedrichTCDoddsEJYantLJVojnovLRudersdorfR 2004 Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med 10 275 281

20. FriedrichTCFryeCAYantLJO'ConnorDHKriewaldtNA 2004 Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response. J Virol 78 2581 2585

21. KobayashiMIgarashiHTakedaAKatoMMatanoT 2005 Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation. J Virol 79 11529 11532

22. EngramJCDunhamRMMakedonasGVanderfordTHSumpterB 2009 Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression. J Immunol 183 706 717

23. BimberBNBurwitzBJO'ConnorSDetmerAGostickE 2009 Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol 83 8247 8253

24. KimEYVeazeyRSZahnRMcEversKJBaumeisterSH 2008 Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys. J Virol 82 5631 5635

25. WalkerBDBurtonDR 2008 Toward an AIDS vaccine. Science 320 760 764

26. BrenchleyJMSchackerTWRuffLEPriceDATaylorJH 2004 CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 749 759

27. GuadalupeMReayESankaranSPrindivilleTFlammJ 2003 Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 77 11708 11717

28. MattapallilJJDouekDCHillBNishimuraYMartinM 2005 Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 1093 1097

29. MehandruSPolesMATenner-RaczKHorowitzAHurleyA 2004 Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200 761 770

30. VeazeyRSDeMariaMChalifouxLVShvetzDEPauleyDR 1998 Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280 427 431

31. van MarleGGillMJKolodkaDMcManusLGrantT 2007 Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology 4 87

32. LayMDPetravicJGordonSNEngramJSilvestriG 2009 Is the gut the major source of virus in early simian immunodeficiency virus infection? J Virol 83 7517 7523

33. CasimiroDRWangFSchleifWALiangXZhangZQ 2005 Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 79 15547 15555

34. FriedrichTCMcDermottABReynoldsMRPiaskowskiSFuengerS 2004 Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts. J Virol 78 10064 10073

35. MandlJNRegoesRRGarberDAFeinbergMB 2007 Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J Virol 81 11982 11991

36. McDermottABO'ConnorDHFuengerSPiaskowskiSMartinS 2005 Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. J Virol 79 15556 15566

37. O'ConnorDHMcDermottABKrebsKCDoddsEJMillerJE 2004 A dominant role for CD8+-T-lymphocyte selection in simian immunodeficiency virus sequence variation. J Virol 78 14012 14022

38. MoniuszkoMBogdanDPalRVenzonDStevcevaL 2005 Correlation between viral RNA levels but not immune responses in plasma and tissues of macaques with long-standing SIVmac251 infection. Virology 333 159 168

39. HansenSGVievilleCWhizinNCoyne-JohnsonLSiessDC 2009 Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15 293 299

40. LiuJO'BrienKLLynchDMSimmonsNLLa PorteA 2009 Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457 87 91

41. HuseSMHuberJAMorrisonHGSoginMLWelchDM 2007 Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol 8 R143

42. FischerWGanusovVVGiorgiEEHraberPTKeeleBF 2010 Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5 e12303